IMCB PJSC Logo

IMCB PJSC

Personal biobank preserving umbilical cord stem cells for families' future therapeutic use.

GEMA | MOEX

Overview

Corporate Details

ISIN(s):
RU000A100GC7
LEI:
Country:
Russian Federation
Address:
Gubkina St. House 3, 11933 Moscow
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

IMCB PJSC is a biotechnology company and a leading personal stem cell biobank, operating under the Gemabank brand. The company specializes in the processing and long-term cryopreservation of hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from umbilical cord tissue. These services provide families with a personalized biological resource for potential use in cell therapy to treat a wide range of hematological, immune, and genetic disorders. Established in 2003, the company manages tens of thousands of client biomaterial samples and has a documented history of successfully providing them for clinical applications. IMCB is also engaged in research and development of innovative gene therapy and biopharmaceutical products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IMCB PJSC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMCB PJSC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMCB PJSC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Hoth Therapeutics, Inc. Logo
Advancing therapeutics for metabolic, dermatologic, and inflammatory diseases.
United States of America
HOTH
Human Stem Cells Institute PJSC Logo
A biotech investor developing gene therapy, regenerative medicine, and genetic services.
Russian Federation
ISKJ
HVIVO PLC Logo
A CRO running human challenge trials to test infectious disease vaccines for pharma/biotech clients.
United Kingdom
HVO
Hybrigenics SA Logo
R&D provider of molecular interaction analysis to accelerate drug discovery for life science sectors.
France
ALHYG
Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.
South Korea
187660
HYUNDAI BIOSCIENCE CO., LTD. Logo
Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.
South Korea
048410
ICON PLC Logo
Global CRO providing outsourced development & commercialization for pharma, biotech & device firms.
United States of America
ICLR
IGC Pharma, Inc. Logo
Clinical-stage pharma creating Alzheimer's therapies & AI-powered diagnostics.
United States of America
IGC
Immuneering Corp Logo
Clinical-stage oncology firm using bioinformatics to develop oral MEK inhibitors for solid tumors.
United States of America
IMRX
IMMUNIC, INC. Logo
Developing oral small molecule therapies for chronic inflammatory and autoimmune diseases.
United States of America
IMUX

Talk to a Data Expert

Have a question? We'll get back to you promptly.